Prism AI
AI platform for discovering complex multi-omics signatures for personalized medicine.
About
Prism AI provides a cloud computing platform with a novel AI approach specifically designed for biomarker discovery from real-life clinical trial data. Their technology aims to enable personalized medicine by detecting and targeting complex multi-omics signatures. Teams look it up for Life Sciences, Drug Development, Biomarkers.
Frequently asked
What does Prism AI do?
Prism AI is a Life Sciences company that offers Software. Teams look it up for Drug Development, Biomarkers, Genomics. It is based in San Francisco, United States and was founded in 2024. Public records show about 4 people and $12M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Prism AI raised?
Prism AI has raised a total of $12M in funding. The most recent round on record is Bootstrapped.
Where is Prism AI headquartered?
Prism AI is headquartered in San Francisco, United States.
When was Prism AI founded?
Prism AI was founded in 2024.
What industry does Prism AI operate in?
Prism AI operates in Life Sciences, Drug Development, Biomarkers, Genomics, Quantum Computing.
How many employees does Prism AI have?
Prism AI has approximately 4 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.